80957-68-2

Basic information

• Product Name: 2-P-TOLYL-4,5,6,7-TETRAHYDRO-OXAZOLO[5,4-C]PYRIDINE
• Synonyms: 5,6,7,8-TETRAHYDRO-[1,6]NAPHTHYRIDINE;1,6-Naphthyridine, 5,6,7,8-tetrahydro-;5,6,7,8-tetrahydro-1,6-naphthyridine(SALTDATA: 2HCl 0.5H2O);5,6,7,8-tetrahydro-1,6-naphthyridine HCl Salt
• CAS NO: 80957-68-2
• Molecular Formula: C₈H₁₀N₂
• Molecular Weight: 134.18
• Product Categories: CHIRAL CHEMICALS;Heterocycle-Pyridine series
• Mol File: 80957-68-2.mol
• Article Data: 10

Chemical Properties

• Boiling Point: 47.62 °C at 760 mmHg
• Flash Point: 103.557 °C
• Appearance: /
• Density: 1.069 g/cm³
• Storage Temp.: Keep in dark place,Sealed in dry,Room Temperature
• PKA: 7.95±0.20(Predicted)
• CAS DataBase Reference: 2-P-TOLYL-4,5,6,7-TETRAHYDRO-OXAZOLO[5,4-C]PYRIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-P-TOLYL-4,5,6,7-TETRAHYDRO-OXAZOLO[5,4-C]PYRIDINE(80957-68-2)
• EPA Substance Registry System: 2-P-TOLYL-4,5,6,7-TETRAHYDRO-OXAZOLO[5,4-C]PYRIDINE(80957-68-2)

Safety Data

• Hazardous Substances Data: 80957-68-2(Hazardous Substances Data)

Usage

Description

2-P-TOLYL-4,5,6,7-TETRAHYDRO-OXAZOLO[5,4-C]PYRIDINE is a chemical compound that serves as an intermediate in the synthesis of various organic compounds.

Uses

Used in Pharmaceutical Industry:
2-P-TOLYL-4,5,6,7-TETRAHYDRO-OXAZOLO[5,4-C]PYRIDINE is used as a synthetic intermediate for the preparation of quinolizidinone carboxylic acid selective M1 allosteric modulators, which have potential applications in the treatment of neurological disorders and cognitive impairments.

Synthetic route

3-bromo-5,6,7,8-tetrahydro-1,6-naphthyridine (625100-00-7) → 5,6,7,8-tetrahydro-1,6-naphthyridine (80957-68-2)

Conditions	Yield
With palladium 10% on activated carbon; hydrogen In ethanol under 2844.39 Torr; for 3.5h;	100%
With palladium 10% on activated carbon; hydrogen In ethanol under 2844.39 Torr; for 3.5h;	0.5 g

6-benzyl-5,6,7,8-tetrahydro-1,6-naphthyridine (75510-02-0) → 5,6,7,8-tetrahydro-1,6-naphthyridine (80957-68-2)

Conditions	Yield
With hydrogen; palladium on activated charcoal In acetic acid at 50 - 60℃;	94%
With palladium on activated charcoal; hydrogen; acetic acid under 2585.81 Torr; for 48h;	64%
With hydrogen; palladium 10% on activated carbon In acetic acid at 50 - 60℃; under 760.051 Torr; for 2h;	60%
With hydrogen; acetic acid; palladium on activated charcoal at 50 - 60℃; for 2h;

1-phenylmethyl-4-piperidone (3612-20-2) → 5,6,7,8-tetrahydro-1,6-naphthyridine (80957-68-2)

Conditions	Yield
Multi-step reaction with 2 steps 1: Et3N; pyridinium acetate / 22 h / 120 °C 2: H2; AcOH / Pd/C / 2 h / 50 - 60 °C View Scheme
Multi-step reaction with 2 steps 1: 37 percent / Et3N, piperidinium acetate / 24 h / 120 °C 2: 94 percent / H2 / Pd-C / acetic acid / 50 - 60 °C View Scheme
Multi-step reaction with 2 steps 1: sodium tetrachloroaurate(III) dihydrate / ethanol / 8 h / 90 °C / Sealed tube 2: palladium on activated charcoal; hydrogen; acetic acid / 48 h / 2585.81 Torr View Scheme

methyl 2-methylnicotinate (65719-09-7) → 5,6,7,8-tetrahydro-1,6-naphthyridine (80957-68-2)

Conditions

Yield

Multi-step reaction with 4 steps 1.1: N-Bromosuccinimide; 2,2'-azobis(isobutyronitrile) / tetrachloromethane / 16 h / 90 °C / Inert atmosphere 2.1: tetrabutyl ammonium fluoride / acetonitrile / 16 h / 0 - 30 °C / Inert atmosphere 3.1: hydrogen / methanol; water / 16 h / 50 °C / 2585.81 Torr 4.1: dimethylsulfide borane complex / tetrahydrofuran; dichloromethane / 16 h / 0 - 90 °C 4.2: 0.25 h / 30 °C 4.3: 3 h / 0 - 90 °C View Scheme

methyl 2-(bromomethyl)pyridine-3-carboxylate (116986-08-4) → 5,6,7,8-tetrahydro-1,6-naphthyridine (80957-68-2)

Conditions	Yield
Multi-step reaction with 3 steps 1.1: tetrabutyl ammonium fluoride / acetonitrile / 16 h / 0 - 30 °C / Inert atmosphere 2.1: hydrogen / methanol; water / 16 h / 50 °C / 2585.81 Torr 3.1: dimethylsulfide borane complex / tetrahydrofuran; dichloromethane / 16 h / 0 - 90 °C 3.2: 0.25 h / 30 °C 3.3: 3 h / 0 - 90 °C View Scheme

methyl 2-(cyanomethyl)nicotinate → 5,6,7,8-tetrahydro-1,6-naphthyridine (80957-68-2)

Conditions	Yield
Multi-step reaction with 2 steps 1.1: hydrogen / methanol; water / 16 h / 50 °C / 2585.81 Torr 2.1: dimethylsulfide borane complex / tetrahydrofuran; dichloromethane / 16 h / 0 - 90 °C 2.2: 0.25 h / 30 °C 2.3: 3 h / 0 - 90 °C View Scheme

7,8-Dihydro-1,6-Naphthyridine-5(6H)-one (155058-02-9) → 5,6,7,8-tetrahydro-1,6-naphthyridine (80957-68-2)

Conditions	Yield
Stage #1: 7,8-Dihydro-1,6-Naphthyridine-5(6H)-one With dimethylsulfide borane complex In tetrahydrofuran; dichloromethane at 0 - 90℃; for 16h; Stage #2: In methanol at 30℃; for 0.25h; Stage #3: With hydrogenchloride In 1,4-dioxane at 0 - 90℃; for 3h;

3-bromo-2-picoline (38749-79-0) → 5,6,7,8-tetrahydro-1,6-naphthyridine (80957-68-2)

Conditions

Yield

Multi-step reaction with 5 steps 1.1: triethylamine; [1,1'-bis(diphenylphosphino)ferrocene]dichloropalladium(II) / 16 h / 80 °C / 2585.81 Torr 2.1: N-Bromosuccinimide; 2,2'-azobis(isobutyronitrile) / tetrachloromethane / 16 h / 90 °C / Inert atmosphere 3.1: tetrabutyl ammonium fluoride / acetonitrile / 16 h / 0 - 30 °C / Inert atmosphere 4.1: hydrogen / methanol; water / 16 h / 50 °C / 2585.81 Torr 5.1: dimethylsulfide borane complex / tetrahydrofuran; dichloromethane / 16 h / 0 - 90 °C 5.2: 0.25 h / 30 °C 5.3: 3 h / 0 - 90 °C View Scheme

1-phenylpiperidin-4-one (19125-34-9) → 5,6,7,8-tetrahydro-1,6-naphthyridine (80957-68-2)

Conditions	Yield
Multi-step reaction with 2 steps 1: sodium tetrachloroaurate(III) dihydrate / ethanol / Reflux 2: hydrogen; palladium on activated charcoal / acetic acid / 2 h / 60 °C View Scheme

6-phenyl-5,6,7,8-tetrahydro-1,6-naphthyridine → 5,6,7,8-tetrahydro-1,6-naphthyridine (80957-68-2)

Conditions	Yield
With palladium on activated charcoal; hydrogen In acetic acid at 60℃; for 2h;

6-chloro-4-methyl-3-nitro-2-pyrrolidin-1-yl-pyridine (1253378-59-4) + 5,6,7,8-tetrahydro-1,6-naphthyridine (80957-68-2) → 6-(4-methyl-5-nitro-6-pyrrolidin-1-yl-pyridin-2-yl)-5,6,7,8-tetrahydro-[1,6]-naphthyridine (1253378-62-9)

Conditions	Yield
With triethylamine In dimethyl sulfoxide at 110℃; for 8h; Microwave irradiation;	100%

5,6,7,8-tetrahydro-1,6-naphthyridine (80957-68-2) → 7,8-dihydro-1,6-naphthyridine (1430218-32-8)

Conditions	Yield
With manganese(IV) oxide In dichloromethane; dimethyl sulfoxide at 20℃; for 24h;	100%

4-((4-(bromomethyl)benzyl)oxy)-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione (1323408-40-7) + 5,6,7,8-tetrahydro-1,6-naphthyridine (80957-68-2) → 4-((4-((7,8-DIHYDRO-1,6-NAPHTHYRIDIN-6(5H)-YL)METHYL) BENZYL)OXY)-2-(2,6-DIOXOPIPERIDIN-3-YL)ISOINDOLINE-1,3-DIONE (1323403-44-6)

Conditions	Yield
With N-ethyl-N,N-diisopropylamine In acetonitrile at 20℃; for 17h;	99%

2-chloropropionyl chloride (7623-09-8) + 5,6,7,8-tetrahydro-1,6-naphthyridine (80957-68-2) → 6-(2-chloropropionyl)-5,6,7,8-tetrahydro-1,6-naphthyridine (95395-45-2)

Conditions	Yield
With triethylamine In chloroform Ambient temperature;	89%

3-[4-[[4-(bromomethyl)phenyl]methoxy]-1-oxo-isoindolin-2-yl]piperidine-2,6-dione (1323407-86-8) + 5,6,7,8-tetrahydro-1,6-naphthyridine (80957-68-2) → 3-(4-((4-((7,8-DIHYDRO-1,6-NAPHTHYRIDIN-6(5H)-YL)METHYL) BENZYL)OXY)-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE (1323403-58-2)

Conditions	Yield
With N-ethyl-N,N-diisopropylamine In acetonitrile at 20℃; for 1h;	88%

trans-chrotonyl chloride (625-35-4, 3488-22-0, 10487-71-5) + 5,6,7,8-tetrahydro-1,6-naphthyridine (80957-68-2) → 6-crotonoyl-5,6,7,8-tetrahydro-1,6-naphthyridine (95395-49-6)

Conditions	Yield
With pyridine In chloroform 1.) 2 h, 5 deg C; 2.) r.t.;	84%

5,6,7,8-tetrahydro-1,6-naphthyridine (80957-68-2) + 2-bromoethanol (540-51-2) → 6-(2-hydroxyethyl)-5,6,7,8-tetrahydro-1,6-naphthyridine (95395-56-5)

Conditions	Yield
With triethylamine In ethanol for 9.5h; Heating;	69%

1-(2-chloropropionyl)-4-(2-methoxyphenyl)piperazine (95395-48-5) + 5,6,7,8-tetrahydro-1,6-naphthyridine (80957-68-2) → 6-<2-<4-(2-methoxyphenyl)-1-piperazinyl>-1-methyl-2-oxoethyl>-5,6,7,8-tetrahydro-1,6-naphthyridine (95395-47-4)

Conditions	Yield
With triethylamine In ethanol Heating;	60%

5,6,7,8-tetrahydro-1,6-naphthyridine (80957-68-2) + acetyl chloride (75-36-5) → 6-Acetyl-5,6,7,8-tetrahydro-1,6-naphthyridine (90781-15-0)

Conditions	Yield
With triethylamine In dichloromethane	58%

5,6,7,8-tetrahydro-1,6-naphthyridine (80957-68-2) + 1-bromo-3-propanol (627-18-9) → 6-(3-hydroxypropyl)-5,6,7,8-tetrahydro-1,6-naphthyridine (75510-13-3)

Conditions	Yield
With triethylamine In ethanol Heating;	56%

di-tert-butyl dicarbonate (24424-99-5) + 5,6,7,8-tetrahydro-1,6-naphthyridine (80957-68-2) → 7,8-dihydro-5H-[1,6]naphthyridine-6-carboxylic acid tert-butyl ester (259809-44-4)

Conditions	Yield
With sodium hydroxide In water; toluene for 0.333333h;	55%
With sodium hydroxide In toluene for 0.166667h;	981 mg

trimethylsilyl cyanide (7677-24-9) + 5,6,7,8-tetrahydro-1,6-naphthyridine (80957-68-2) → 5,6,7,8-tetrahydro-1,6-naphthyridine-6-nitrile

Conditions	Yield
With potassium fluoride; tetrabutylammomium bromide In acetonitrile at 20℃; for 3h;	47%

2-(5-amino-2-(furan-2-yl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-7-yl)-2-phenylacetic acid + 5,6,7,8-tetrahydro-1,6-naphthyridine (80957-68-2) → 2-(5-amino-2-(furan-2-yl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-7-yl)-1-(7,8-dihydro-1,6-naphthyridin-6 (5H)-yl)-2-phenylethan-1-one

Conditions	Yield
With N-ethyl-N,N-diisopropylamine; HATU In N,N-dimethyl-formamide at 20℃; for 16h;	44%

C16H13ClFN5 + 5,6,7,8-tetrahydro-1,6-naphthyridine (80957-68-2) → C24H22FN7

Conditions	Yield
With N-ethyl-N,N-diisopropylamine at 120℃; Sealed tube;	39%

C17H15ClFN5 + 5,6,7,8-tetrahydro-1,6-naphthyridine (80957-68-2) → C25H24FN7

Conditions	Yield
With N-ethyl-N,N-diisopropylamine Sealed tube;	39%

C16H12ClF2N5 + 5,6,7,8-tetrahydro-1,6-naphthyridine (80957-68-2) → C24H21F2N7

Conditions	Yield
With N-ethyl-N,N-diisopropylamine at 130℃; for 8h;	39%

C16H10ClFN4 + 5,6,7,8-tetrahydro-1,6-naphthyridine (80957-68-2) → C26H21FN6

Conditions	Yield
With N-ethyl-N,N-diisopropylamine at 130℃; for 12h;	38%

5,6,7,8-tetrahydro-1,6-naphthyridine (80957-68-2) + phosphonic acid diethyl ester (762-04-9) → diethyl (5,6,7,8-tetrahydro-1,6-napthyridin-5-yl)phosphonate

Conditions	Yield
With sodium acetate; lithium perchlorate In acetonitrile at 20℃; for 6h; Electrolysis;	38%

C17H14ClFN4 + 5,6,7,8-tetrahydro-1,6-naphthyridine (80957-68-2) → C25H23FN6

Conditions	Yield
With N-ethyl-N,N-diisopropylamine at 120℃; Sealed tube;	35%

1-methyl-6-(3-(oxiran-2-ylmethoxy)phenyl)-1H-benzo[d]imidazole (1616059-77-8) + 5,6,7,8-tetrahydro-1,6-naphthyridine (80957-68-2) → 1-(7,8-dihydro-1,6-naphthyridin-6(5H)-yl)-3-(3-(1-methyl-1H-benzo[d]imidazol-6-yl)phenoxy)propan-2-ol

Conditions	Yield
In ethanol at 80℃; for 5h;	25.4%

N-(2-hydroxy-3-iodopropyl)-2-(quinolin-8-yloxy)acetamide + 5,6,7,8-tetrahydro-1,6-naphthyridine (80957-68-2) → N-[2-hydroxy-3-(5,6,7,8-tetrahydro-1,6-naphthyridin-6-yl)propyl]-2-(quinolin-8-yloxy)acetamide

Conditions	Yield
In methanol at 80℃; for 24h;	19%

tert-butyl cyclopentyl(3-(oxiran-2-ylmethoxy)benzyl)carbamate (1616059-87-0) + 5,6,7,8-tetrahydro-1,6-naphthyridine (80957-68-2) → tert-butyl cyclopentyl(3-(3-(7,8-dihydro-1,6-naphthyridin-6(5H)-yl)-2-hydroxypropoxy)benzyl)carbamate

Conditions	Yield
In ethanol at 100℃; for 0.5h; Microwave irradiation;	8.7%

4-methacryloyl-4-(2-methoxyphenyl)piperazine (96743-74-7) + 5,6,7,8-tetrahydro-1,6-naphthyridine (80957-68-2) → 6-<3-<4-(2-methoxyphenyl)-1-piperazinyl>-2-methyl-3-oxopropyl>-5,6,7,8-tetrahydro-1,6-naphthyridine (95395-52-1)

Conditions	Yield
With N-benzyl-trimethylammonium hydroxide In ethanol Heating;

1-crotonoyl-4-(2-methoxyphenyl)piperazine (95395-50-9) + 5,6,7,8-tetrahydro-1,6-naphthyridine (80957-68-2) → 6-<3-<4-(2-methoxyphenyl)-1-piperazinyl>-1-methyl-3-oxopropyl>-5,6,7,8-tetrahydro-1,6-naphthyridine (95395-51-0)

Conditions	Yield
With N-benzyl-trimethylammonium hydroxide In ethanol Heating;

5,6,7,8-tetrahydro-1,6-naphthyridine (80957-68-2) → 5,6,7,8-tetrahydro-[1,6]naphthyridine-2-carboxylic acid methyl ester (1057855-79-4)

Conditions	Yield
Multi-step reaction with 4 steps 1: 981 mg / aq. NaOH / toluene / 0.17 h 2: 98 percent / m-chloroperbenzoic acid / CH2Cl2 / 0.5 h / 0 °C 3: 88 percent / N,N-dimethylcarbamyl chloride / CH2Cl2 / 41 h / 20 °C 4: aq. HCl / 3 h / 100 °C View Scheme

5,6,7,8-tetrahydro-1,6-naphthyridine (80957-68-2) → 6-(tert-butoxycarbonyl)-5,6,7,8-tetrahydro-1,6-naphthyridine-1-oxide (259809-45-5)

Conditions	Yield
Multi-step reaction with 2 steps 1: 981 mg / aq. NaOH / toluene / 0.17 h 2: 98 percent / m-chloroperbenzoic acid / CH2Cl2 / 0.5 h / 0 °C View Scheme

Upstream product

• 75510-02-0 6-benzyl-5,6,7,8-tetrahydro-1,6-naphthyridine 
• 19125-34-9 1-phenylpiperidin-4-one 
• 38749-79-0 3-bromo-2-picoline 
• 155058-02-9 7,8-Dihydro-1,6-Naphthyridine-5(6H)-one 
• 116986-08-4 methyl 2-(bromomethyl)pyridine-3-carboxylate 
• 65719-09-7 methyl 2-methylnicotinate 
• 625100-00-7 3-bromo-5,6,7,8-tetrahydro-1,6-naphthyridine 
• 3612-20-2 1-phenylmethyl-4-piperidone 

Downstream Products

• 1201844-61-2 N-(2-chloro-5-(7,8-dihydro-1,6-naphthyridin-6(5H)-yl)pyridin-3-yl)-4-fluorobenzenesulfonamide 
• 1366240-41-6 N-(2-fluoro-4-chlorophenyl)-4-[(7,8-dihydro-1,6-naphthyridin-6(5H)-yl)carbonyl]-( 5-methyl)1,3-thiazol-2-amine 
• 1036381-91-5 tert‐butyl 2‐oxo‐1,5,7,8‐tetrahydro‐1,6‐naphthyridine‐6(2H)‐carboxylate 
• 676994-33-5 2-[4-(3,5-dichloro-phenoxy)-5-methyl-2H-pyrazol-3-yl]-1-(7,8-dihydro-5H-[1,6]naphthyridin-6-yl)-ethanone 
• 95355-91-2 6-<2-<4-(2-butoxyphenyl)-1-piperazinyl>ethyl>-5,6,7,8-tetrahydro-1,6-naphthyridine 
• 95356-01-7 6-<2-<4-(2,5-dimethoxyphenyl)-1-piperazinyl>ethyl>-5,6,7,8-tetrahydro-1,6-naphthyridine 
• 83081-86-1 6-{3-[4-(2-Methoxy-phenyl)-piperazin-1-yl]-butyl}-5,6,7,8-tetrahydro-[1,6]naphthyridine 
• 95355-89-8 6-<2-<4-(2-propoxyphenyl)-1-piperazinyl>ethyl>-5,6,7,8-tetrahydro-1,6-naphthyridine 
• 83081-50-9 6-{3-[4-(2-Methoxy-phenyl)-piperazin-1-yl]-propyl}-5,6,7,8-tetrahydro-[1,6]naphthyridine 
• 95356-04-0 6-{2-[4-(2-Methoxy-phenyl)-piperazin-1-yl]-propyl}-5,6,7,8-tetrahydro-[1,6]naphthyridine 
• 83100-35-0 6-<2-<4-(2-ethoxyphenyl)-1-piperazinyl>ethyl>-5,6,7,8-tetrahydro-1,6-naphthyridine 
• 83081-88-3 6-{3-[4-(2-Methoxy-phenyl)-piperazin-1-yl]-2-methyl-propyl}-5,6,7,8-tetrahydro-[1,6]naphthyridine 
• 83081-63-4 6-{3-[4-(2-Ethoxy-phenyl)-piperazin-1-yl]-propyl}-5,6,7,8-tetrahydro-[1,6]naphthyridine 
• 83081-73-6 6-{2-[4-(2-Methoxy-phenyl)-piperazin-1-yl]-1-methyl-ethyl}-5,6,7,8-tetrahydro-[1,6]naphthyridine 

Relevant articles and documents

Compound as potassium channel modulator

The invention relates to a compound as a potassium channel modulator, which is a compound of a formula (I) or a pharmaceutically acceptable salt thereof. The compound or the pharmaceutically acceptable salt thereof is effective for curing and preventing diseases and symptoms influenced by the activity of potassium ion channels.

Heterocyclic compound with Wnt signal path inhibitory activity and application thereof

The invention provides a heterocyclic compound with Wnt signal path inhibitory activity. The heterocyclic compound and chemically acceptable salt, isotope, isomer and a crystal structure thereof are provided with a structure shown as the general formula I (see the formula in the description). The invention further provides application of the heterocyclic compound with the Wnt signal path inhibitory activity. The heterocyclic compound with the Wnt signal path inhibitory activity serves as effective antagonist of a Wnt signal path, and can be used for treating or preventing diseases caused by abnormity of the Wnt signal path.

SUBSTITUTED TETRAHYDROISOQUINOLINE COMPOUNDS AS FACTOR XIA INHIBITORS

The present invention provides compounds of Formula (I): or stereoisomers, pharmaceutically acceptable salts thereof, wherein all of the variables are as defined herein. These compounds are inhibitors of factor XIa and/or plasma kallikrein which may be used as medicaments.